University of Missouri

July 17, 2024

University of Missouri Research Reactor joins Nuclear Medicine Europe

July 12, 2024

Innovations and information

IT leaders from across the SEC gathered at Mizzou for their annual meeting.

June 4, 2024

Michael Hoehn II named inaugural program director of NextGen MURR

Hoehn will lead Mizzou’s transformational initiative to build a new state-of-the-art research reactor that will expand medical isotope production.

March 28, 2024

Innovative yttrium-90 radioisotopes revolutionize liver cancer treatment

Yttrium-90 radioisotopes produced at the University of Missouri Research Reactor are extending and improving the lives of patients with liver cancer.

Jan. 30, 2024

Sparking innovation for research

A scanning electron microscope at the University of Missouri Research Reactor will enhance the facility’s investigative capabilities for materials research and discoveries.

Dec. 13, 2023

MU Health Care pilots breakthrough treatment for prostate cancer

Treatment uses radioisotopes produced in the University of Missouri Research Reactor.

Dec. 6, 2023

MU Research Reactor announces commercial shipments of breakthrough radioisotope for cancer treatment

The University of Missouri Research Reactor (MURR) is the only U.S. supplier of the radioisotope, produced using a propriety process developed at MURR.

Nov. 7, 2023

Tiny atoms, big impact: How the MU Research Reactor is saving and improving lives in Missouri and around the globe

The NextGen MURR initiative will expand the University of Missouri’s capacity to produce medical isotopes that will be used in advanced cancer treatments for decades to come.

Oct. 2, 2023

University of Missouri breaks ground on addition to MU Research Reactor facility

The new $20 million, three-story addition to the existing MURR North Building will expand the facility’s production space and testing laboratories.

Sept. 28, 2023

MEDIA ADVISORY: MU hosts groundbreaking ceremony for addition to Research Reactor facility